Bacterium used to tackle Dengue fever

NewsGuard 100/100 Score

This January Australian scientists will start deploying a strange bacterium called Wolbachia pipientis in an attempt to halt disease transmission by mosquitoes especially Dengue fever. They are targeting the Aedes aegypti mosquito that transmits Dengue. Dengue is a viral disease that leads to high fever, severe muscle and joint pain and can also be fatal.

In recent studies, scientists have found that infection with Wolbachia makes mosquitoes resistant to the Dengue virus. Now, a team led by Scott O'Neill of the University of Queensland in Brisbane wants to test whether they can spread Wolbachia in the wild by setting free small numbers of mosquitoes infected with the microbe. Wolbachia also alters the reproduction of these mosquitoes making them multiply faster they said.

The experiments would be conducted in two towns in Queensland. Actual trial that would help would come after approval in Vietnam and Thailand where the disease is rampant they said. O'Neill said, “We wanted to start in our own backyard.” In another experiment a few weeks ago genetically sterile mosquitoes were tried on the Caribbean island of Grand Cayman.

Jason Rasgon, an entomologist at Johns Hopkins University in Baltimore, Maryland said both studies are groundbreaking. “If you had asked me 5 years ago when we would start releasing Wolbachia-infected mosquitoes, I might have said, ‘20 years from now,’ ” he said. Wolbachia lives inside the cells of more than half of all insect species, including many mosquitoes, but not the most important disease vectors. Female insects pass the bacteria on to their offspring via their eggs but when an uninfected female mates with an infected male, there are no viable offspring. This ensures a fast spread. O'Neill said this is simple with no genetic modification needed. Wolbachia has now become the weapon itself he explained. “You can think of it as a vaccine for mosquitoes,” he added.

As of now the team plans to release about 10 mosquitoes a week per household for 12 weeks. The goal is to find out how well the microbe spreads. Based on mathematical models, O'Neill thinks the infection could travel about 10 kilometers a year. Not every Ae. aegypti mosquito in the world will eventually become infected, he says. Geographical barriers keep separate populations apart. There is, of course, the possibility that mosquitoes or the pathogens will adapt to elude Wolbachi’s effects experts warn.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Bacterium used to tackle Dengue fever. News-Medical. Retrieved on April 18, 2024 from https://www.news-medical.net/news/20101209/Bacterium-used-to-tackle-Dengue-fever.aspx.

  • MLA

    Mandal, Ananya. "Bacterium used to tackle Dengue fever". News-Medical. 18 April 2024. <https://www.news-medical.net/news/20101209/Bacterium-used-to-tackle-Dengue-fever.aspx>.

  • Chicago

    Mandal, Ananya. "Bacterium used to tackle Dengue fever". News-Medical. https://www.news-medical.net/news/20101209/Bacterium-used-to-tackle-Dengue-fever.aspx. (accessed April 18, 2024).

  • Harvard

    Mandal, Ananya. 2018. Bacterium used to tackle Dengue fever. News-Medical, viewed 18 April 2024, https://www.news-medical.net/news/20101209/Bacterium-used-to-tackle-Dengue-fever.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals high insomnia rates in non-hospitalized COVID-19 survivors